Previous studies have shown that high expression of PPM1D predicts poor outcome in NB patients, which suggests PPM1D may play a critical role in the tumorigenesis of NB22 and therefore may have value as a therapeutic target in NB. Here, PPM1D is linked to neuroblastoma.